New Drugs FDA Approves Talvey (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma 1 year ago
Pharma Industry News How is pharma engaging with HCPs? Educational platforms and activities 1 year ago